Key result
Telemedicine and artificial intelligence techniques are being developed to improve heart failure management, though their clinical safety and potential benefits remain under debate.
Why the study?
Although AI and new monitoring technologies may improve heart failure management, the assessment of clinical safety and evaluation of potential benefits remain a matter of debate.
This review highlights the potential of telemedicine and artificial intelligence to improve heart failure management and the need to assess their clinical safety and benefits.
Cautions against routine use of telemedicine and AI in heart failure pending safety confirmation; leaves open optimal implementation strategies for prospective trials.
New technologies have been recently introduced to improve the monitoring of patients with chronic syndromes such as heart failure. Devices can now be employed to gather large amounts of data and data processing through artificial intelligence techniques may improve heart failure management and reduce costs. The analysis of large datasets using an artificial intelligence technique is leading to a paradigm shift in the era of precision medicine. However, the assessment of clinical safety and the evaluation of the potential benefits is still a matter of debate. In this article, the authors aim to focus on the development of these new tools and to draw the attention to their transition in daily clinical practice.
No takes yet. Share an insight, caveat, or question.
D’Amario et al. (2020) conducted a review in Heart failure. Telemedicine and Artificial Intelligence was evaluated. Telemedicine and artificial intelligence techniques are being developed to improve heart failure management, though their clinical safety and potential benefits remain under debate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: